Hepatoprotective Effect of Ulinastatin in a Rat Model of Major Hepatectomy After Obstructive Jaundice
- 3 February 2015
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (6) , 1680-1689
Abstract
To date, major hepatectomy with obstructive jaundice is still a highly risky and difficult surgery because of the high rate of complications. An excessive inflammatory response may be the primary hindrance to postoperative recovery of liver function. Recent research has demonstrated that ulinastatin blocks the release of inflammatory factors and prevents the cytokine cascade reaction. This study was conducted to investigate the effect of ulinastatin on major hepatectomy after obstructive jaundice and to explore the potential mechanisms of this effect. Male Sprague–Dawley rats were divided into three groups: sham, control and treated groups. In the control and treated groups, obstructive jaundice was induced, and a 70 % major hepatectomy was performed with implementation of ulinastatin treatment in the treated group but not the control group. The rats were sacrificed after hepatectomy on day 1, day 3, day 5 and day 7. The survival time, liver function, inflammatory cytokine expression and the indices of proliferation activities were examined. Kupffer cells were isolated, and the mRNA and protein levels of CD14 and NF-κB P65 in the Kupffer cells were determined. Compared to the control group, the survival rates, postoperative liver function, and the indices of proliferation activities were better in the treated group; in the treated group serum TNF-α and IL-6 levels were lower whereas serum IL-10 levels were higher. The expression of CD14 and NF-κB P65 in Kupffer cells at both the mRNA and protein levels was significantly higher in the control group than in the treated group. Ulinastatin has a protective effect in major hepatectomy with obstructive jaundice by inhibiting Kupffer cell activation and modulating the hepatic cytokine response.Keywords
This publication has 38 references indexed in Scilit:
- Kupffer cells regulate the progression of ALD and NAFLDNature Reviews Gastroenterology & Hepatology, 2013
- Asia–Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinomaJournal of Gastroenterology and Hepatology, 2013
- A clinical prospective comparison of anesthetics sensitivity and hemodynamic effect among patients with or without obstructive jaundiceActa Anaesthesiologica Scandinavica, 2010
- Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatmentJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- The Effect of Insulin-like Growth Factor-I on Hepatocyte Apoptosis After Bile Duct Ligation in RatDigestive Diseases and Sciences, 2006
- Toll–Like Receptor 4 Mediates Inflammatory Signaling by Bacterial Lipopolysaccharide in Human Hepatic Stellate CellsHepatology, 2003
- Cytokine Cascades and the Hepatic Inflammatory Response to Ischemia and ReperfusionJournal of Investigative Surgery, 2003
- Alterations of tumor necrosis factor‐alpha and interleukin 6 production and activity of the reticuloendothelial system in experimental obstructive jaundice in ratsHPB, 2002
- Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat kupffer cellsHepatology, 1999
- Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor κBHepatology, 1999